Article Information
- March 27, 2021.
Article Versions
- Version 1 (February 8, 2021 - 03:24).
- You are viewing Version 2, the most recent version of this article.
REVISION SUMMARY
Criteria used for chronic graft-versus-host disease diagnosis and scoring included; better description of the underlying diseases in the study cohort provided (Table 1); references in the Discussion section updated.
Author Information
- Vitor Heidrich1,2,
- Julia S. Bruno1,
- Franciele H. Knebel1,
- Vinícius C. de Molla3,4,
- Wanessa Miranda-Silva1,
- Paula F. Asprino1,
- Luciana Tucunduva3,
- Vanderson Rocha3,5,6,
- Yana Novis3,
- Celso Arrais-Rodrigues3,4,
- Eduardo R. Fregnani3 and
- Anamaria A. Camargo3,*
- 1Centro de Oncologia Molecular, Hospital Sírio Libanês, São Paulo, SP, Brazil
- 2Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, SP, Brazil
- 3Centro de Oncologia, Hospital Sírio Libanês, São Paulo, SP, Brazil
- 4Universidade Federal de São Paulo, São Paulo, SP, Brazil
- 5Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo/ICESP, São Paulo, SP, Brazil
- 6Churchill Hospital, NHS-BT, Oxford, United Kingdom
- ↵*Corresponding author
Anamaria Aranha Camargo, E-mail: anamaria.acamargo{at}hsl.org.br, Centro de Oncologia Molecular, Hospital Sírio-Libanês, Rua Prof. Daher Cutait, 69, 01308-060 São Paulo - SP - Brasil, Phone: +55 11 3394-4180
Authors’ contribution VH, JSB, FHK and VCM are co-first authors; AAC and ERF designed the study; FHK, PFA, VH, JSB and WMS performed the sequencing; VH and AAC developed the bioinformatics pipeline; VH, JSB, VCM, CAR, ERF, and AAC contributed to the analysis and interpretation of data; VH, JSB, VCM, CAR and AAC contributed to writing the manuscript. All authors have read and approved the final manuscript. All authors are accountable for all aspects of the work.